Compass Therapeutics, Inc.
CMPX
7 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 2 12:00 PM | Neil LernerChief Accounting Officer | Purchase | 20,000 | $0.92 | $18.4K | 420,000(D) | View → |
| Sep 24, 2026 | Sep 25 12:01 PM | Neil LernerChief Accounting Officer | Purchase | 2,500 | $1.14 | $2.8K | 400,000(D) | View → |
| Apr 29, 2026 | Apr 30 8:00 PM | Neil LernerChief Accounting Officer | Purchase | 15,000 | $1.89 | $28.4K | 397,500(D) | View → |
| Apr 29, 2026 | Apr 30 8:00 PM | Jonathan AndermanGeneral Counsel | Purchase | 25,000 | $1.89 | $47.3K | 196,000(D) | View → |
| Apr 9, 2025 | Apr 9 10:58 PM | OrbiMed Genesis Master Fund, L.P. | Proposed Sale | 3,571,428 | $1.59 | $5.7M | — | View → |
| Apr 9, 2025 | Apr 9 10:51 PM | The Biotech Growth Trust PLC | Proposed Sale | 3,571,428 | $1.59 | $5.7M | — | View → |
Stock Options & Derivatives
No transactions found.